Effect of Aromatherapy on Anxiety in Relatives of Emergency Patients.

February 12, 2026 updated by: Serafettin Okutan, Bitlis Eren University

Principal Investigator, Assistant Professor Şerafettin OKUTAN, Surgical Nursing, Faculty of Health Sciences, Bitlis Eren University

This study aims to determine the effect of aromatherapy (lavender oil) application on the anxiety level of relatives of patients admitted to the emergency department.

The hypotheses of the study are as follows:

H1: Aromatherapy (lavender oil) application has an effect on the anxiety level of relatives of patients presenting to the emergency department.

H0: Aromatherapy (lavender oil) application has no effect on the anxiety level of relatives of patients presenting to the emergency department.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

In the experimental group; After the patient is registered in the emergency department, the participant introduction form and state-trait anxiety scales will be applied as a pre-test to the relatives of the patients who agree to participate in the study. The participants will be made to smell lavender oil dropped on gauze by the researchers for an average of 3-5 minutes. After the intervention, the state and trait anxiety scales will be applied as a post-test approximately 15 minutes later.

In the control group; After the patient is registered in the emergency department, the participant introduction form and state-trait anxiety scales will be applied as a pre-test to the relatives of the patients who agree to participate in the study. No intervention will be made to the participants in the control group. After a certain waiting period (after an average of 15 minutes), the state and trait anxiety scales will be applied as a post-test.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Bitlis
      • Bitlis, Bitlis, Turkey (Türkiye), 13100
        • Bitlis Eren University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Being 18 years of age or older
  2. Not having a problem with smell
  3. Accompanying the patient
  4. Not having a psychiatric problem

Exclusion Criteria:

  1. Refusing to participate in the study or wanting to leave
  2. Having an upper respiratory tract infection
  3. Known history of allergy (lavender oil)
  4. Having a chronic respiratory disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
Intervention Group After the patient is registered in the emergency department, the participant introduction form and state-trait anxiety scales will be applied as a pre-test to the relatives of the patient who agree to participate in the study. The participants will be made to smell lavender oil dropped on gauze by the researchers for an average of 3-5 minutes. The state and trait anxiety scales will be applied as a post-test approximately 15 minutes after the intervention.
Other: aromatherapy
Lavender oil dropped on gauze will be smelled for approximately 3-5 minutes.
No Intervention: Control Group
Control Group After the patient is registered in the emergency department, the participant introduction form and state-trait anxiety scales will be applied as a pre-test to the relatives of the patient who agree to participate in the study. No intervention will be made to the control group participants. After a certain waiting period (average of 15 minutes), the state and trait anxiety scales will be applied as a post-test.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
anxiety level
Time Frame: It will take approximately 30 minutes.

The anxiety levels of patients will be measured using the "State and Trait Anxiety Scale".

State and Trait Anxiety Scale; consists of two scales. Each scale has 20 questions. Scoring is between 1-4. Each scale score varies between 20-80 points. A high scale score indicates high anxiety. A low scale score indicates low anxiety.
It will take approximately 30 minutes.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Bitlis Eren University

Investigators

  • Principal Investigator: Şerafettin OKUTAN, Dr., Bitlis Eren University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2025

Primary Completion (Actual)

September 1, 2025

Study Completion (Actual)

October 30, 2025

Study Registration Dates

First Submitted

January 5, 2025

First Submitted That Met QC Criteria

January 9, 2025

First Posted (Actual)

January 10, 2025

Study Record Updates

Last Update Posted (Actual)

February 17, 2026

Last Update Submitted That Met QC Criteria

February 12, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Okutan2

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Clinical Trials on aromatherapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe